Toshiba partners with Fischer Imaging
Dedicated electrophysiology products are joining the product lineup of Toshiba America Medical Systems as part of a sales and marketing strategic alliance between Toshiba and Fischer Imaging. The alliance was struck to allow Fischer Imaging to focus
Dedicated electrophysiology products are joining the product lineup of Toshiba America Medical Systems as part of a sales and marketing strategic alliance between Toshiba and Fischer Imaging. The alliance was struck to allow Fischer Imaging to focus efforts on refining its offerings regarding breast care, according to Fischer. Covered under the agreement are Fischer’s EP table, single-plane EPX, and biplane EPX2 electrophysiology systems. The single- and biplane systems are among the most complete and cost-efficient heart catheterization systems on the market, offering high-resolution imagery and reduced x-ray dosage via pulsed progressive fluoroscopy.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
